PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2011
- Volume 7
- Issue 12
Technical Perspectives: Antibody Drug Conjugates
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the
Articles in this issue
almost 14 years ago
World Health Organization Issues Progress Report on Combating HIV/AIDSalmost 14 years ago
CSR and Sustainability in the Newsalmost 14 years ago
Pharmaceutical Companies Target Green Manufacturingalmost 14 years ago
Biosimilars' Technology NeedsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
